Search

Author/Creator Lechner, Daniel

2. Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population. Issue 2 (28th January 2020)

Authors:
Ludwig, Heinz; Pönisch, Wolfram; Knop, Stefan; Egle, Alexander; Hinke, Axel; Schreder, Martin; Lechner, Daniel; Hajek, Roman; Gunsilius, Eberhard; Petzer, Andreas; Weisel, Katja; Niederwieser, Dietger; Einsele, Hermann; Willenbacher, Wolfgang; Rumpold, Holger; Pour, Ludek; Jelinek, Tomas; Krenosz...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 2(2020)
Page Start:
377
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial). Issue 1 (8th November 2020)

Authors:
Ludwig, Heinz; Hausmann, Bela; Schreder, Martin; Pönisch, Wolfram; Zojer, Niklas; Knop, Stefan; Gunsilius, Eberhard; Egle, Alexander; Petzer, Andreas; Einsele, Hermann; Hajek, Roman; Weisel, Katja; Krenosz, Karl Jochen; Lang, Alois; Lechner, Daniel; Greil, Richard; Berry, David
Journal:
EJHaem
Issue:
Volume 2:Issue 1(2021)
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗